Eculizumab for Shiga‐toxin‐induced hemolytic uremic syndrome in adults with neurological involvement

Abstract The role of eculizumab in treating Shiga‐toxin‐producing Escherichia coli (STEC) hemolytic uremic syndrome (HUS) patients with neurological involvement remains unclear. We describe two distinctly different STEC‐HUS patients with neurologic involvement successfully managed with eculizumab, a...

Full description

Bibliographic Details

Published in:	eJHaem
Main Authors:	Benjamin J. Lee, Zhaohui Arter, Jean Doh, Shawn P. Griffin, Pongthep Vittayawacharin, Steven Atallah, Kevin R. Shieh, Minh‐Ha Tran, Sonata Jodele, Piyanuch Kongtim, Stefan O. Ciurea
Format:	Article
Language:	English
Published:	Wiley 2024-06-01
Subjects:	eculizumab hemolytic uremic syndrome neurological involvement Shiga‐toxin producing Escherichia coli STEC‐HUS
Online Access:	https://doi.org/10.1002/jha2.902